Structure evolution during isothermal crystallization of isotactic polypropylene and the
changes during a subsequent heating to the melt were analyzed by time- and temperature-dependent
small-angle X-ray scattering experiments. Results demonstrate that isotactic polypropylene, when forming
the α-polymorph, is governed by the same general laws for crystallization and melting as syndiotactic
polypropylene. Crystal thicknesses are inversely proportional to the supercooling under a characteristic
temperature
which is located above the equilibrium melting point of a sample. The crystallization
line describing this dependence can be understood as representing the stability limit of a well-defined
initial state with higher free energy. Its transformation into the final lamellar two-phase structure provides
the stabilization expressed in the difference between the crystallization and melting temperature.
Observations and data from other sources can be seen as indicating that (i) crystal thicknesses are
independent of the isotacticity and that (ii) the initial state is composed of crystal blocks in planar
assemblies, in agreement with corresponding observations on syndiotactic polypropylene. The small-angle X-ray scattering experiments provide a detailed insight into the structure changes during the
continuous melting. For high crystallization temperatures no recrystallization occurs. Crystals with
different stabilities, all having the same thickness, melt consecutively. Structures produced at low
crystallization temperatures are less stable. Here heating leads to repeated melting−recrystallization
processes associated with jumplike changes in the length scale of the structure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.